Connecting Digital Health Technologies to Advance Clinical Research

Since 2015 Precision Digital Health (PDH) has been on a mission to enable its clients to run innovative and efficient trials that deliver better insights to improve health outcomes. Its next-generation device agnostic clinical data collection and analysis platform, SUMMA, include interoperable modules designed to support the shift from traditional trials to decentralized digital trial models that while innovative, bring a greater level of complexity due to expanding data sources and workflows required across one or more vendor systems.

The SUMMA platform is uniquely positioned to seamlessly support either traditional or decentralized operational models as a stand-alone solution or an integral part of a partnering DCT (Decentralized Clinical Trials) platform. In either approach, SUMMA’s library of purpose-built connectors enables the collection and efficient orchestration of data workflows from multiple digital sources (Sensors, EDC, EHR, Labs, eCOA, etc.). PDH’s ability to simplify complex workflows resulting from numerous data sources sets it apart and provides clinical research partners with greater control of decentralized trials.

On multiple occasions during the COVID-19 pandemic, Pharma Sponsors and CROs have engaged PDH to rescue trials challenged by siloed data and burdensome workflow. As a result, PDH has established itself as a proven and reliable research partner by enabling the successful execution of next-generation, large scale, clinical trial designs across the globe.

To summarize: PDH empowers organizations of all sizes to improve clinical research operational and business results by simplifying the complexity of decentralized clinical trials. Our deep drug and device clinical development knowledge and experience, global reach, purpose-built solutions, and deployment agility accelerate and materially impact our customers’ business outcomes.